Hmdb loader
Survey
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-11 17:29:59 UTC
Update Date2022-07-15 00:38:55 UTC
HMDB IDHMDB0029365
Secondary Accession Numbers
  • HMDB29365
Metabolite Identification
Common NameN-trans-feruloyltyramine
DescriptionN-trans-feruloyltyramine (NFT), also known as Moupinamide or Alfrutamide or N-feruloyltyramine or trans-N-Feruloyltyramine, belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. It is also classified as a phenylpropanoid amide. Phenylpropanoids consist of a six-carbon, aromatic phenyl group and a three-carbon propene tail of coumaric acid, which is the central intermediate in phenylpropanoid biosynthesis. A phenylpropanoid amide has an amide group incorporated into its propanoid chain. There are two known isomers of N-Feruloyltyramine, N-trans-Feruloyltyramine and N-cis-Feruloyltyramine. N-trans-feruloyltyramine (Moupinamide) is a largely neutral molecule, that is somewhat insoluble in water. It exists as a white crystalline solid. Moupinamide or N-trans-Feruloyltyramine is one of the major phenylpropanoid amides that have been identified in the cannabis plant (PMID:6991645 ). It is also found in black and white peppers, the leaves of the Chinese pepper tree as well as eggplant (PMID: 34335243 ). This could make moupinamide a potential biomarker for the consumption of these plants/foods. Moupinamide is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases, they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. N-trans-feruloyltyramine or NFT has a number of potential therapeutic or beneficial effects in humans. It is an inhibitor of COX 1 and COX 2 and has potential antioxidant properties (PMID: 19807156 ). More recently, trans-N-Caffeoyltyramine has been identified to by a potent HNF4α agonist (PMID: 35087037 ). HNF4A or HNF4α is also known as Hepatocyte nuclear factor 4 alpha. It is also known as NR2A1 (nuclear receptor subfamily 2, group A, member 1 and) is a nuclear receptor that in humans is encoded by the HNF4A gene. Moupinamide (NFT) has been found to promote weight loss by inducing an increase in mitochondrial mass and function, including fatty acid oxidation. It also promotes the reversal of hepatic steatosis through a mechanism involving the stimulation of lipophagy by dihydroceramides (PMID: 34117215 ). This has made Moupinamide or NFT a strong candidate as a NAFLD (non-alcoholic fatty liver disease) therapeutic.
Structure
Data?1657845534
Synonyms
ValueSource
N-[(e)-Feruloyl]tyramineChEBI
trans-N-FeruloyltyramineChEBI
Feruloyltyramine, (Z)-isomerMeSH
N-FeruloyltyramineMeSH
FeruloyltyramineMeSH
Feruloyltyramine, (e)-isomerMeSH
(2,3)trans-N-(P-Hydroxyphenethyl)ferulamideHMDB
N-trans-FeruloyltyramineHMDB
MoupinamideChEBI
(2E)-3-(4-Hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidate HMDB
(2,3) trans-N-(P-Hydroxyphenethyl)ferulamide HMDB
(2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-2-propenamideHMDB
(2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamideHMDB
NFTHMDB
AlfrutamideHMDB
3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-2-PropenamideHMDB
Chemical FormulaC18H19NO4
Average Molecular Weight313.3478
Monoisotopic Molecular Weight313.131408101
IUPAC Name(Z,2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid
Traditional Name(Z,2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid
CAS Registry Number66648-43-9
SMILES
COC1=CC(\C=C\C(=O)NCCC2=CC=C(O)C=C2)=CC=C1O
InChI Identifier
InChI=1S/C18H19NO4/c1-23-17-12-14(4-8-16(17)21)5-9-18(22)19-11-10-13-2-6-15(20)7-3-13/h2-9,12,20-21H,10-11H2,1H3,(H,19,22)/b9-5+
InChI KeyNPNNKDMSXVRADT-WEVVVXLNSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety.
KingdomOrganic compounds
Super ClassBenzenoids
ClassPhenols
Sub ClassMethoxyphenols
Direct ParentMethoxyphenols
Alternative Parents
Substituents
  • Methoxyphenol
  • Phenoxy compound
  • Anisole
  • Methoxybenzene
  • Phenol ether
  • Styrene
  • Alkyl aryl ether
  • 1-hydroxy-2-unsubstituted benzenoid
  • Monocyclic benzene moiety
  • Carboximidic acid
  • Carboximidic acid derivative
  • Ether
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Organooxygen compound
  • Organopnictogen compound
  • Organic nitrogen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
Biological locationRoute of exposureSource
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting Point144.5 - 145 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility382.8 mg/L @ 25 °C (est)The Good Scents Company Information System
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.013 g/LALOGPS
logP2.46ALOGPS
logP3.05ChemAxon
logS-4.4ALOGPS
pKa (Strongest Acidic)4.41ChemAxon
pKa (Strongest Basic)6.38ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area82.28 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity90.09 m³·mol⁻¹ChemAxon
Polarizability34.56 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+171.87230932474
DeepCCS[M-H]-169.51430932474
DeepCCS[M-2H]-203.51830932474
DeepCCS[M+Na]+178.98730932474
AllCCS[M+H]+175.532859911
AllCCS[M+H-H2O]+172.232859911
AllCCS[M+NH4]+178.632859911
AllCCS[M+Na]+179.532859911
AllCCS[M-H]-177.632859911
AllCCS[M+Na-2H]-177.532859911
AllCCS[M+HCOO]-177.532859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
MoupinamideCOC1=CC(\C=C\C(=O)NCCC2=CC=C(O)C=C2)=CC=C1O4532.8Standard polar33892256
MoupinamideCOC1=CC(\C=C\C(=O)NCCC2=CC=C(O)C=C2)=CC=C1O3004.2Standard non polar33892256
MoupinamideCOC1=CC(\C=C\C(=O)NCCC2=CC=C(O)C=C2)=CC=C1O3323.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Moupinamide,1TMS,isomer #1COC1=CC(/C=C/C(=O)NCCC2=CC=C(O[Si](C)(C)C)C=C2)=CC=C1O3250.6Semi standard non polar33892256
Moupinamide,1TMS,isomer #2COC1=CC(/C=C/C(=O)NCCC2=CC=C(O)C=C2)=CC=C1O[Si](C)(C)C3286.1Semi standard non polar33892256
Moupinamide,1TMS,isomer #3COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O)C=C2)[Si](C)(C)C)=CC=C1O3255.3Semi standard non polar33892256
Moupinamide,2TMS,isomer #1COC1=CC(/C=C/C(=O)NCCC2=CC=C(O[Si](C)(C)C)C=C2)=CC=C1O[Si](C)(C)C3316.2Semi standard non polar33892256
Moupinamide,2TMS,isomer #2COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C)C=C2)[Si](C)(C)C)=CC=C1O3177.3Semi standard non polar33892256
Moupinamide,2TMS,isomer #3COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O)C=C2)[Si](C)(C)C)=CC=C1O[Si](C)(C)C3244.2Semi standard non polar33892256
Moupinamide,3TMS,isomer #1COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C)C=C2)[Si](C)(C)C)=CC=C1O[Si](C)(C)C3225.4Semi standard non polar33892256
Moupinamide,3TMS,isomer #1COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C)C=C2)[Si](C)(C)C)=CC=C1O[Si](C)(C)C2960.5Standard non polar33892256
Moupinamide,1TBDMS,isomer #1COC1=CC(/C=C/C(=O)NCCC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)=CC=C1O3543.7Semi standard non polar33892256
Moupinamide,1TBDMS,isomer #2COC1=CC(/C=C/C(=O)NCCC2=CC=C(O)C=C2)=CC=C1O[Si](C)(C)C(C)(C)C3560.7Semi standard non polar33892256
Moupinamide,1TBDMS,isomer #3COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O)C=C2)[Si](C)(C)C(C)(C)C)=CC=C1O3494.3Semi standard non polar33892256
Moupinamide,2TBDMS,isomer #1COC1=CC(/C=C/C(=O)NCCC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)=CC=C1O[Si](C)(C)C(C)(C)C3839.5Semi standard non polar33892256
Moupinamide,2TBDMS,isomer #2COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)=CC=C1O3684.1Semi standard non polar33892256
Moupinamide,2TBDMS,isomer #3COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O)C=C2)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C3726.3Semi standard non polar33892256
Moupinamide,3TBDMS,isomer #1COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C3948.7Semi standard non polar33892256
Moupinamide,3TBDMS,isomer #1COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C3534.5Standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - N-trans-feruloyltyramine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4j-0930000000-0d34a7b54bbeaebc282b2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - N-trans-feruloyltyramine GC-MS (2 TMS) - 70eV, Positivesplash10-00dl-9433600000-1e204cd575b97a4b0e8e2017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - N-trans-feruloyltyramine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - N-trans-feruloyltyramine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - N-trans-feruloyltyramine , negative-QTOFsplash10-03di-0509000000-7a8a88d076bfbf1cf48c2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - N-trans-feruloyltyramine , positive-QTOFsplash10-00ba-1900000000-1acd727ab1a27d74943c2017-09-14HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 10V, Positive-QTOFsplash10-01p9-0902000000-35cbd3fbcb8058d643292016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 20V, Positive-QTOFsplash10-00kr-0900000000-714a65fcbd5aa8249bea2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 40V, Positive-QTOFsplash10-0avs-3900000000-cdd8344e1c4c188399fb2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 10V, Negative-QTOFsplash10-03di-0419000000-87271f4c26fc442256b32016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 20V, Negative-QTOFsplash10-08ic-0922000000-64a362d838af2e86e0dc2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 40V, Negative-QTOFsplash10-002f-3900000000-b725e376ed0d4ee8b4052016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 10V, Positive-QTOFsplash10-03di-0209000000-c1a4d6d9de34cccce22b2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 20V, Positive-QTOFsplash10-03k9-0913000000-efa7c33a7ab2898ad0e32021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 40V, Positive-QTOFsplash10-00di-2920000000-c1af345555bf57620ee12021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 10V, Negative-QTOFsplash10-03di-0009000000-5cd9c8e6e0b2900b51af2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 20V, Negative-QTOFsplash10-01ri-0902000000-10d6192946f54c2146a72021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-trans-feruloyltyramine 40V, Negative-QTOFsplash10-000x-1920000000-bbb470c57468688aaedc2021-09-22Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm
  • Extracellular
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB000432
KNApSAcK IDC00000660
Chemspider ID4444168
KEGG Compound IDC02717
BioCyc IDCPD-440
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound5280537
PDB IDNot Available
ChEBI ID17818
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDrw1808791
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Turner CE, Elsohly MA, Boeren EG: Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod. 1980 Mar-Apr;43(2):169-234. doi: 10.1021/np50008a001. [PubMed:6991645 ]
  2. Song Y, Mei T, Liu Y, Kong S, Zhang J, Xie M, Ou S, Liang M, Wang Q: Metabolites Identification of Chemical Constituents From the Eggplant (Solanum melongena L.) Calyx in Rats by UPLC/ESI/qTOF-MS Analysis and Their Cytotoxic Activities. Front Pharmacol. 2021 Jul 15;12:655008. doi: 10.3389/fphar.2021.655008. eCollection 2021. [PubMed:34335243 ]
  3. Park JB: Isolation and characterization of N-feruloyltyramine as the P-selectin expression suppressor from garlic (Allium sativum). J Agric Food Chem. 2009 Oct 14;57(19):8868-72. doi: 10.1021/jf9018382. [PubMed:19807156 ]
  4. Veeriah V, Lee SH, Levine F: Long-term oral administration of an HNF4alpha agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function. Cell Death Dis. 2022 Jan 27;13(1):89. doi: 10.1038/s41419-022-04521-5. [PubMed:35087037 ]
  5. Lee SH, Veeriah V, Levine F: Liver fat storage is controlled by HNF4alpha through induction of lipophagy and is reversed by a potent HNF4alpha agonist. Cell Death Dis. 2021 Jun 11;12(6):603. doi: 10.1038/s41419-021-03862-x. [PubMed:34117215 ]
  6. (). Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.. .